根据脑卒中病人临床神经功能缺损程度评分(NDS)标准评分。
All the patients were scored by clinic neurological function deficit scale (NDS).
治疗后分别进行脑卒中的临床神经功能缺损程度评分及ADL缺陷程度评分。
After the treatment, clinical nerve function damage degree was marked as well as the ADL flaw degree.
分析各组临床神经功能缺损程度评分及TCD、血流变的改善情况，评价其疗效及安全性。
Dialysis all the groups the melioration of defect severity of clinical neural function, hemorrheology and TCD changes and evaluated its effect and safety.
结论急性脑梗死患者血清钙、镁浓度降低，且其降低程度与临床神经功能缺损程度评分相关。
Conclusion the concentration of serum calcium and magnesium in acute cerebral infarction is decreased, and the degree of decrease was related with the clinical nerve deficiency scale.
方法运用脑卒中患者临床神经功能缺损程度评分标准进行评分、划分严重程度、确定疗效等级。
Method Clinical neural function deficit score criteria for stroke was used to evaluate the severity and the curative effect.
治疗前后采用脑卒中临床神经功能缺损程度评分量表，肩关节疾患治疗成绩判定标准和手掌手指功能评价进行评判。
Use the measure of nerve function defect grade in the wind stroke, score evaluation of the shoulder disease, hand function evaluation to evaluate the effect of the fore-and-aft the treatment.
结果：养阴活血方治疗糖尿病性脑梗死临床疗效、改善临床神经功能缺损程度评分积分、降低空腹血糖等优于西药常规治疗。
Results: as to the clinical effect, the scoring of neural function and the decrease of fasting blood glucose, YHF was more effective than routine western medicine.
结论CRP水平是临床评估aci患者神经功能缺损程度和近期预后的重要生物学指标。
Conclusion Serum level of CRP is an important biological marker to evaluate the degree of nervous function defect and recent prognosis in ACI.
结论：颈动脉注射黄芪血塞通结合针剌星状神经节能显著提高脑梗死患者的临床疗效，降低神经功能缺损程度。
Conclusion: Huangqi-xuesaitong carotid injection and acupuncture ganglion of stellatum can obviously improve clinical effects of cerebral infarction patients and reduce neurological deficit.
结果丹奥和葛根素治疗急性脑梗死的临床显效率及神经功能缺损程度评分明显优于对照组（P<0.01）。
Results The effect of ozagrel with puerarin was better in treatment group than that in the control group(P<0.01).
结果丹奥和葛根素治疗急性脑梗死的临床显效率及神经功能缺损程度评分明显优于对照组（P<0.01）。
Results The effect of ozagrel with puerarin was better in treatment group than that in the control group(P<0.01).
应用推荐